Cargando…
Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica
Neuromyelitis optica (NMO) is an autoimmune disease associated with NMO immunoglobulin G (NMO-IgG), an antibody that selectively binds to the aquaporin-4. Here, we established a localized NMO model by injecting NMO-IgG into the spinal cord, and assessed the efficacy of treating its NMO-like symptoms...
Autores principales: | Harada, Kana, Fujita, Yuki, Okuno, Tatsusada, Tanabe, Shogo, Koyama, Yoshihisa, Mochizuki, Hideki, Yamashita, Toshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758562/ https://www.ncbi.nlm.nih.gov/pubmed/29311561 http://dx.doi.org/10.1038/s41598-017-18362-2 |
Ejemplares similares
-
The roles of RGMa-neogenin signaling in inflammation and angiogenesis
por: Fujita, Yuki, et al.
Publicado: (2017) -
Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder
por: Yamashita, Kazuya, et al.
Publicado: (2018) -
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS
por: Shimizu, Mikito, et al.
Publicado: (2023) -
Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation
por: Shimizu, Mikito, et al.
Publicado: (2020) -
Activated Microglia Inhibit Axonal Growth through RGMa
por: Kitayama, Mari, et al.
Publicado: (2011)